Business development
Investment Opportunities
Investors of Biosun Pharmed
To optimize operations and mitigate business risks, companies frequently enter into strategic business partnerships. These collaborations take various forms, including strategic alliances with competitors and non-competitors, joint ventures, and buyer-supplier relationships. In its pursuit of excellence and the advancement of the pharmaceutical industry, Biosun Pharmed announces its readiness for partnership with both domestic and international companies.
1. Natural and Herbal Medicine Production Project (Barekat Pharmaceutical Group)
Barekat Pharmaceutical Group has planned and invested in this production chain with the goal of providing effective natural pharmaceutical products capable of competing in global markets. This initiative relies on Iran’s traditional knowledge and the country’s vast potential to create high-value-added products.
Key Outcomes of the Project:
Capturing the large and untapped market for Iranian medicinal plants and natural products in regional and international countries.
Improving the qualitative and quantitative levels of targeted and controlled agriculture to supply standardized raw materials for natural health products.
Establishing the Islamic Republic of Iran’s effective presence in regional and international markets by exporting finished herbal products instead of raw materials.
Creating direct and indirect employment for hundreds of individuals across the country.
Expanding traditional medicine services by producing natural products in modern, globally competitive dosage forms (Industrialization of Traditional Pharmacy).
Supporting underprivileged rural areas through empowerment and direct/indirect participation in production processes.
2. Biosimilar Pharmaceutical Production Project (Biosun Pharmed)
This project focuses on a diverse portfolio of medications for the treatment of hematological (blood) disorders, hormonal imbalances, and other critical conditions.
Project Outcomes:
Capturing the large and unguided market for the consumption of Iranian medicinal plants and natural products in regional and trans-regional countries.
Improving the qualitative and quantitative levels of the targeted and controlled agricultural industry to supply standardized raw materials and produce natural health products in Fars Province and the country.
Effective entry of the Islamic Republic of Iran into regional and trans-regional markets and the export of herbal pharmaceutical products, moving away from raw material sales—from the production of raw materials to final products.
Direct and indirect job creation for hundreds of people in various parts of the country.
Expansion of traditional medicine services in the country by producing natural products in the form of modern and globally competitive dosage forms (Industrialization of Traditional Pharmacy).
Supporting underprivileged rural areas to empower and ensure their direct and indirect participation in production processes.
3. Biosimilar Drug Production Project (Biosun Pharmed)
The products of this plan include various drugs for the treatment of hematological (blood), hormonal, and other diseases. Biosimilar drugs are versions similar to biological drugs and, due to the complexity of the market, these drugs are growing rapidly (faster than the overall pharmaceutical market growth). However, the high price of these drugs remains one of the limiting factors for their consumption.